Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Additionally we are shipping KIR2DL3 Proteins (15) and KIR2DL3 Kits (1) and many more products for this protein.
Showing 10 out of 141 products:
Human Monoclonal KIR2DL3 Primary Antibody for ELISA, WB - ABIN2656950
Döhring, Samaridis, Colonna: Alternatively spliced forms of human killer inhibitory receptors. in Immunogenetics 1996
Show all 10 references for ABIN2656950
Human Monoclonal KIR2DL3 Primary Antibody for FACS - ABIN2659116
Maenaka, Juji, Stuart, Jones: Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. in Structure (London, England : 1993) 1999
Show all 9 references for ABIN2659116
Human Monoclonal KIR2DL3 Primary Antibody for FACS - ABIN2661521
Wagtmann, Rajagopalan, Winter, Peruzzi, Long: Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. in Immunity 1996
Show all 9 references for ABIN2661521
Human Monoclonal KIR2DL3 Primary Antibody for FACS, IP - ABIN118908
Moretta, Tambussi, Bottino, Tripodi, Merli, Ciccone, Pantaleo, Moretta: A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. in The Journal of experimental medicine 1990
Show all 6 references for ABIN118908
Human Monoclonal KIR2DL3 Primary Antibody for EIA, FACS - ABIN121143
Chwae, Chang, Park, Yoon, Park, Kim, Kim: Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. in Journal of immunology (Baltimore, Md. : 1950) 2002
Show all 2 references for ABIN121143
Human Monoclonal KIR2DL3 Primary Antibody for FACS - ABIN120016
Shin, Shin, Kim, Choi, Park, Kim: Monoclonal antibodies with various reactivity to p58 killer inhibitory receptors. in Hybridoma 2000
Human Polyclonal KIR2DL3 Primary Antibody for IF (p), IHC (p) - ABIN748448
Mozer-Lisewska, Mania, Kowala-Piaskowska, Kluk, Samara, Pauli, ?eromski: Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers. in Archivum immunologiae et therapiae experimentalis 2014
KIR2DL2 (show KIR2DL2 Antibodies)/KIR2DL3-glutamate (show GRIN1 Antibodies)(35) alleles are functionally stronger than -glutamine (show GFPT1 Antibodies)(35) alleles.
KIR2DL2 (show KIR2DL2 Antibodies)/2DS2-C1C1 genotype is associated with type 1 diabetes in Saudi children
study compared KIR (show GEM Antibodies) gene repertoire of HIV-1 positive with exposed uninfected (EU)) infants to elucidate its association with transmission; results revealed presence of significantly high frequencies of activating gene KIR (show GEM Antibodies) 2DS5 and inhibitory gene KIR (show GEM Antibodies) 2DL3 in EU infants as compared to HIV-1 positive infants
genetic association study in population in Eastern India: Data suggest that interactions between KIRs (KIR2DL2 (show KIR2DL2 Antibodies), KIR2DS4 (show KIR2DS4 Antibodies), KIR2DL3) and HLA ligands (HLAC1, HLAC2) contribute significantly toward susceptibility and protection toward type 1 diabetes.
Allelic polymorphism of KIR2DL2 (show KIR2DL2 Antibodies)/2DL3 in a southern Chinese population.
The authors have identified a deleterious effect of the KIR2DL3-HLA-C1 receptor-ligand combination on HIV clinical outcomes in a Thai cohort.
Single Nucleotide Polymorphism in KIR2DL3 gene is associated with Asthma and Atopic Dermatitis.
KIR2DL3 has previously been identified as important for clearance of the Hepatitis C virus after established infection,not found to be relevant to resistance to Hepatitis C infection.
Genetic risk for co-occurrence of type 1 diabetes and celiac disease is modified by HLA-C and killer immunoglobulin-like receptors.
CD4(+) CD28(-) cells exhibited increased KIR2DS2, reduced KIR2DL3 and increased DAP12 expression in HD-ESRD compared with NDD-CKD patients.
Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis.
CD158 antigen-like family member B2
, MHC class I NK cell receptor
, killer cell immunoglobulin-like receptor 2DL3
, killer inhibitory receptor cl 2-3
, natural killer associated transcript 2
, natural killer cell inhibitory receptor KIR2DL3
, natural killer-associated transcript 2
, p58 NK receptor CL-6
, p58 natural killer cell receptor clone CL-6
, p58.2 MHC class-I specific NK receptor
, p58.2 MHC class-I-specific NK receptor